Title
About the paper Risk factors of hepatocellular carcinoma in patients with chronic hepatitis C virus infection receiving pegylated interferon ribavirin treatment
Date Issued
01 March 2022
Access level
metadata only access
Resource Type
Controlled Vocabulary for Resource Type Genres::texto::revista::carta al editor
Author(s)
Navarro-Yparraguirre M.M.
Navarro-Yparraguirre M.M.
Arias-Revilla A.O.
Arias-Revilla A.O.
Roque-Quezada J.C.E.
Roque-Quezada J.C.E.
Medicina Humana
Universidad Ricardo Palma
Medicina Humana
Universidad Ricardo Palma
Medicina
Universidad Ricardo Palma
Start page
476
End page
478
Volume
38
Issue
2
DOI
10.24245/mim.v38i2.6966
Scopus EID
2-s2.0-85158153688
Source
Medicina Interna De Mexico
Sources of information: Directorio de Producción Científica Scopus